Display:
Providers:
TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.
|
|
|
|
|
Today's News, September 25, 2023 | ||
---|---|---|
September 22, 2023 | ||
September 21, 2023 | ||
September 20, 2023 | ||
September 19, 2023 | ||
September 18, 2023 | ||
September 15, 2023 | ||
September 14, 2023 | ||
September 13, 2023 | ||
September 12, 2023 | ||
September 11, 2023 | ||
September 08, 2023 | ||
September 07, 2023 | ||
September 06, 2023 | ||
September 05, 2023 | ||
September 01, 2023 | ||
August 31, 2023 | ||
August 30, 2023 | ||
August 29, 2023 | ||
August 28, 2023 | ||
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.